Pennsylvania HB2749 provides immunity from liability for administering opioid antagonists to reverse overdoses.

HB2749 amends the Controlled Substance, Drug, Device and Cosmetic Act to protect individuals and entities from liability when administering opioid antagonists to reverse opioid overdoses. Health professionals who prescribe or dispense these drugs in good faith are immune from criminal, civil, and professional disciplinary actions. Municipalities, local health departments, and community-based organizations that provide expired opioid antagonists are also shielded from liability. Immunity does not apply if the health professional acts with intent to harm or reckless indifference.

Pennsylvania HB2749 provides immunity from liability for administering opioid antagonists to reverse overdoses.

HB2749 amends the Controlled Substance, Drug, Device and Cosmetic Act to protect individuals and entities from liability when administering opioid antagonists to reverse opioid overdoses. Health professionals who prescribe or dispense these drugs in good faith are immune from criminal, civil, and professional disciplinary actions. Municipalities, local health departments, and community-based organizations that provide expired opioid antagonists are also shielded from liability. Immunity does not apply if the health professional acts with intent to harm or reckless indifference.